Literature DB >> 15373967

TLR4 Asp299Gly and Thr399Ile polymorphisms are very rare in the Chinese population.

Jingqing Hang1, Wei Zhou, Hongxi Zhang, Bixiong Sun, Helian Dai, Li Su, David C Christiani.   

Abstract

Endotoxin is an important component of bio-aerosols that contribute to airway inflammation and airflow obstruction. Toll-like receptor 4 (TLR4) mediates the host response to bacterial lipopolysaccharide (LPS), and the Asp299Gly and Thr399Ile polymorphisms have been associated with the development of respiratory diseases. We hypothesized that TLR4 polymorphisms may be associated with a decline of lung function in cotton workers who were exposed continuously to endotoxin. We investigated these two polymorphisms in our 20-year longitudinal cohort of Han Chinese cotton and silk textile workers. The two polymorphisms were genotyped using TaqMan and PCR-restriction fragment length polymorphism methods. No homozygous or heterozygous variant genotypes of the Asp299Gly and Thr339Ile polymorphisms were detected in 491 samples of this population. Our results suggest that the TLR4 Asp299Gly and Thr339Ile polymorphisms are very rare in the Chinese population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15373967     DOI: 10.1179/096805104225005841

Source DB:  PubMed          Journal:  J Endotoxin Res        ISSN: 0968-0519


  18 in total

1.  Toll-like receptor (TLR) 4 polymorphism Asp299Gly is not associated with disease course in Dutch sarcoidosis patients.

Authors:  M Veltkamp; J C Grutters; C H M van Moorsel; H J T Ruven; J M M van den Bosch
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

2.  Lack of association of TLR4 gene Asp299Gly and Thr399Ile polymorphisms with rheumatoid arthritis in Chinese Han population of Yunnan Province.

Authors:  Bingrong Zheng; Qin Li; Chuanyu Wei; Jiao Qin; Tao Shou; Ruoyu Zhou; Jingru Shao; Yan Yang; Chunjie Xiao
Journal:  Rheumatol Int       Date:  2010-03-20       Impact factor: 2.631

3.  TLR and MBL gene polymorphisms in severe acute pancreatitis.

Authors:  DianLiang Zhang; HongMei Zheng; YanBing Zhou; BaoJun Yu; JieShou Li
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

4.  Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection.

Authors:  Yonghong Li; Monica Chang; Olivia Abar; Veronica Garcia; Charles Rowland; Joseph Catanese; David Ross; Samuel Broder; Mitchell Shiffman; Ramsey Cheung; Teresa Wright; Scott L Friedman; John Sninsky
Journal:  J Hepatol       Date:  2009-06-18       Impact factor: 25.083

5.  Sequence variants of toll like receptor 4 and late-onset Alzheimer's disease.

Authors:  Yen-Ching Chen; Ping-Keung Yip; Yi-Ling Huang; Yu Sun; Li-Li Wen; Yi-Min Chu; Ta-Fu Chen
Journal:  PLoS One       Date:  2012-12-18       Impact factor: 3.240

6.  Rarity of TLR4 Asp299Gly and Thr399Ile polymorphisms in the Korean population.

Authors:  Yeun Sun Kim; You Jin Hwang; Sung Yong Kim; Sun Mee Yang; Ki Young Lee; Ie Byung Park
Journal:  Yonsei Med J       Date:  2008-02-29       Impact factor: 2.759

7.  Association of the TLR4 Asp299Gly polymorphism with lung function in relation to body mass index.

Authors:  Punam Pahwa; Chandima P Karunanayake; Donna C Rennie; Yue Chen; David A Schwartz; James A Dosman
Journal:  BMC Pulm Med       Date:  2009-09-21       Impact factor: 3.317

8.  Frequency of TLR 2, 4, and 9 gene polymorphisms in Chinese population and their susceptibility to type 2 diabetes and coronary artery disease.

Authors:  Fengjing Liu; Weixin Lu; Qiaohui Qian; Weigang Qi; Jifan Hu; Bo Feng
Journal:  J Biomed Biotechnol       Date:  2012-10-03

9.  A 5'-flanking region polymorphism in toll-like receptor 4 is associated with gastric cancer in a Chinese population.

Authors:  Hua Huang; Juan Wu; Guangfu Jin; Hanze Zhang; Yanbing Ding; Zhaolai Hua; Yan Zhou; Yan Xue; Yan Lu; Zhibin Hu; Yaochu Xu; Hongbing Shen
Journal:  J Biomed Res       Date:  2010-03

10.  TLR9 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis.

Authors:  Xiaoyong Wang; Lening Xue; Yang Yang; Lijuan Xu; Guoxin Zhang
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.